Sustainable Respiratory Inhalers Programme - briefing note

The continued use of metered-dose inhalers in respiratory care will have a potentially catastrophic effect on global warming if production is not controlled, largely because these inhalers use potent green-house gas hydroflourocarbons (HFCs) as propellants. A cost-effective and safe alternative is available in the form of Dry Powder Inhalers (DPIs). This briefing note sets out the case for a programme to change prescribing practices such that DPIs are used in preference to HFC-driven inhalers where not clinically contra-indicated.